Predictors of failure in timely tuberculosis treatment completion, United States

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 8, 2012, Pages 1075-1082

  Mitruka, Kiren ^a   Winston, C A ^a   Navin, T R ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Disease notification; Extra pulmonary; Pulmonary; Treatment; Tuberculosis

Indexed keywords

RIFAMPICIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; ASIAN; CAUCASIAN; DIRECTLY OBSERVED THERAPY; DRUG TREATMENT FAILURE; ETHNIC DIFFERENCE; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HISPANIC; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL EXPERT; NEGRO; PATIENT COMPLIANCE; POISSON DISTRIBUTION; PREDICTION; PRIORITY JOURNAL; PRISON; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ADULT; AGED; ANTITUBERCULAR AGENTS; COINFECTION; COMORBIDITY; DIRECTLY OBSERVED THERAPY; DOCUMENTATION; EMIGRATION AND IMMIGRATION; ETHNIC GROUPS; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; LINEAR MODELS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TUBERCULOSIS; UNITED STATES; YOUNG ADULT;

EID: 84862559117     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0814     Document Type: Article

References (27)

1. Centers for Disease Control and Prevention. Treatment of tuberculosis: American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2003; 52 (RR-11): 1-77.
2. Guy E S, Mallampalli A. Managing TB in the 21st century: existing and novel drug therapies. Ther Adv Respir Dis 2008; 2: 401-408.
3. Centers for Disease Control and Prevention. Controlling tuberculosis in the United States: recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep 2005; 54(RR-12): 1-81.
4. Binkin N J, Vernon A A, Simone P M, et al. Tuberculosis prevention and control activities in the United States: an overview of the organization of tuberculosis services. Int J Tuberc Lung Dis 1999; 3: 663-674. (Pubitemid 29378466)
5. Centers for Disease Control and Prevention. Monitoring tuberculosis programs: National Tuberculosis Indicator Project, United States, 2002-2008. MMWR Morb Mortal Wkly Rep 2010; 59: 295-298.
6. Lobato M N, Wang Y C, Becerra J E, Simone P M, Castro K G. Improved program activities are associated with decreasing tuberculosis incidence in the United States. Public Health Rep 2006; 121: 108-115.
7. McKenna M T, McCray E, Jones J L, Onorato I M, Castro K G. The fall after the rise: tuberculosis in the United States, 1991 through 1994. Am J Public Health 1998; 88: 1059-1063. (Pubitemid 28319361)
8. Centers for Disease Control and Prevention. National TB Indicators Project: initial indicators and performance targets. Atlanta, GA, USA: CDC, 2011. http://www.cdc.gov/tb/programs/Evaluation/Indicators/methodology.htm Accessed April 2012.
9. Centers for Disease Control and Prevention. Reported tuberculosis in the United States, 2008. Atlanta, GA, USA: US Dept of Health and Human Services, Centers for Disease Control and Prevention, 2009.
10. Bloch A B, Cauthen G M, Simone P M, Kelly G D, Dansbury K G, Castro K G. Completion of tuberculosis therapy for patients reported in the United States in 1993. Int J Tuberc Lung Dis 1999; 3: 273-280. (Pubitemid 29166820)
11. Centers for Disease Control and Prevention. Report of verified case of tuberculosis (RVCT) instruction manual. Atlanta, GA, USA: US Department of Health and Human Services, Centers for Disease Control and Prevention, 2009.
12. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004; 159: 702-706. (Pubitemid 38405384)
13. SAS Institute Inc. SAS/STAT® 9.22 user's guide: the GENMOD procedure. Cary, NC, USA: SAS Institute, 2010.
14. Schneider E, Castro K G. Tuberculosis trends in the United States, 1992-2001. Tuberculosis (Edinb) 2003; 83: 21-29. (Pubitemid 36683546)
15. Centers for Disease Control and Prevention. Trends in tuberculosis - United States, 2008. MMWR Morb Mortal Wkly Rep 2009; 58: 249-253.
16. Monteon M L, Arcari C M, Remington P L, Kanarek M S, Oemig T V. Tuberculosis cases in Wisconsin: documentation of treatment improvement and completion of treatment, 2000-2002. J Public Health Manag Pract 2006; 12: 254-261. (Pubitemid 44132985)
17. MacNeil J R, Lobato M N, Moore M. An unanswered health disparity: tuberculosis among correctional inmates, 1993 through 2003. Am J Public Health 2005; 95: 1800-1805. (Pubitemid 41369052)
18. Cummings K C, Mohle-Boetani J, Royce S E, Chin D P. Movement of tuberculosis patients and the failure to complete antituberculosis treatment. Am J Respir Crit Care Med 1998; 157 (4 Pt 1): 1249-1252.
19. Lobato M N, Roberts C A, Bazerman L B, Hammett T M. Public health and correctional collaboration in tuberculosis control. Am J Prev Med 2004; 27: 112-117. (Pubitemid 38942940)
20. Centers for Disease Control and Prevention. Post-detention completion of tuberculosis treatment for persons deported or released from the custody of the Immigration and Naturalization Service-United States, 2003. MMWR 2003; 52: 438-441.
21. Schneider D L, Lobato M N. Tuberculosis control among people in US Immigration and Customs Enforcement custody. Am J Prev Med 2007; 33: 9-14. (Pubitemid 46899389)
22. Borgdorff M W, Veen J, Kalisvaart N A, Broekmans J F, Nagelkerke N J. Defaulting from tuberculosis treatment in the Netherlands: rates, risk factors and trend in the period 1993-1997. Eur Respir J 2000; 16: 209-213. (Pubitemid 30624937)
23. Chin D P, Cummings K C, Sciortino S, et al. Progress and problems in achieving the United States national target for completion of antituberculosis treatment. Int J Tuberc Lung Dis 2000; 4: 744-751. (Pubitemid 30654793)
24. Driver C R, Matus S P, Bayuga S, Winters A I, Munsiff S S. Factors associated with tuberculosis treatment interruption in New York City. J Public Health Manag Pract 2005; 11: 361-368.
25. Buchanan R J. Compliance with tuberculosis drug regimens: incentives and enablers offered by public health departments. Am J Public Health 1997; 87: 2014-2017. (Pubitemid 28055923)
26. Marks S M, DeLuca N, Walton W. Knowledge, attitudes and risk perceptions about tuberculosis: US National Health Interview Survey. Int J Tuberc Lung Dis 2008; 12: 1261-1267.
27. Sprinson J E, Lawton E S, Porco T C, Flood J M, Westenhouse J L. Assessing the validity of tuberculosis surveillance data in California. BMC Public Health 2006; 6: 217.